Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+70.2%
5Y CAGR+9.5%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
+70.2%/yr
Annual compound
5Y CAGR
+9.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
4 yr
Consecutive growthElevated
PeriodValueYoY Change
20240.51+8.4%
20230.47+288.4%
20220.12+17.1%
20210.10+259.9%
20200.03-91.1%
20190.32-